Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.23 is 45% below its 5-year average of 2.25, near the low end of its 5-year range (1.23–3.67).
As of the fiscal period ended Tuesday, June 30, 2026. 11.79% below its 12-month average of 1.39.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.23.
QUICK RATIO (ACID-TEST)
1.23
QUICK RATIO (ACID-TEST) AVG TTM
1.39
QUICK RATIO (ACID-TEST) AVG 3Y
1.74
QUICK RATIO (ACID-TEST) AVG 5Y
2.25
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-11.79%
CURRENT VS 3Y AVG
-29.37%
CURRENT VS 5Y AVG
-45.33%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 563 covered companies
CURRENT VS SECTOR MEDIAN
-58.88%
vs the sector median at left
Astrana Health, Inc.
Market Cap
$1.85B
Quick Ratio (Acid-Test)
1.23
TTM Avg
1.39
3Y Avg
1.74
5Y Avg
2.25
Market Cap
$1.84B
Quick Ratio (Acid-Test)
13.96
TTM Avg
11.13
3Y Avg
7.91
5Y Avg
6.39
Market Cap
$1.86B
Quick Ratio (Acid-Test)
9.79
TTM Avg
11.31
3Y Avg
11.94
5Y Avg
12.05
Market Cap
$1.87B
Quick Ratio (Acid-Test)
10.63
TTM Avg
5.62
3Y Avg
5.25
5Y Avg
6.00
Market Cap
$1.89B
Quick Ratio (Acid-Test)
7.14
TTM Avg
4.14
3Y Avg
3.11
5Y Avg
3.56
Market Cap
$1.78B
Quick Ratio (Acid-Test)
6.65
TTM Avg
5.42
3Y Avg
7.28
5Y Avg
7.47
Market Cap
$1.75B
Quick Ratio (Acid-Test)
8.30
TTM Avg
3.78
3Y Avg
3.78
5Y Avg
3.78
Market Cap
$1.95B
Quick Ratio (Acid-Test)
2.52
TTM Avg
2.21
3Y Avg
2.25
5Y Avg
2.64
Market Cap
$1.73B
Quick Ratio (Acid-Test)
1.07
TTM Avg
0.89
3Y Avg
0.95
5Y Avg
0.97
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Astrana Health, Inc. (ASTH) | $1.85B | 1.23 | 1.39 | 1.74 | 2.25 |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.84B | 13.96 | 11.13 | 7.91 | 6.39 |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.86B | 9.79 | 11.31 | 11.94 | 12.05 |
| Absci Corporation (ABSI)vs › | $1.87B | 10.63 | 5.62 | 5.25 | 6.00 |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 7.14 | 4.14 | 3.11 | 3.56 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | 6.65 | 5.42 | 7.28 | 7.47 |
| Generate Biomedicines, Inc. (GENB)vs › | $1.75B | 8.30 | 3.78 | 3.78 | 3.78 |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.95B | 2.52 | 2.21 | 2.25 | 2.64 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | 1.07 | 0.89 | 0.95 | 0.97 |
| Immunome, Inc. (IMNM)vs › | $1.99B | 15.08 | 9.38 | 7.12 | 8.07 |
Quick Ratio
1.23
Excludes inventory
Current Ratio
1.23
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.23 |
| 2026-03-31 | 1.35 |
| 2025-12-31 | 1.40 |
| 2025-09-30 | 1.40 |
| 2025-06-30 | 1.59 |
| 2025-03-31 | 1.70 |
| 2024-12-31 | 1.75 |
| 2024-09-30 | 1.91 |
| 2024-06-30 | 1.84 |
| 2024-03-31 | 1.51 |
| 2023-12-31 | 2.11 |
| 2023-09-30 | 2.35 |
| 2023-06-30 | 2.50 |
| 2023-03-31 | 2.76 |
| 2022-12-31 | 2.88 |
| 2022-09-30 | 2.84 |
| 2022-06-30 | 2.49 |
| 2022-03-31 | 2.77 |
| 2021-12-31 | 3.53 |
| 2021-09-30 | 3.66 |
| 2021-06-30 | 3.67 |
